Qube Research & Technologies (QRT)’s Pacific Biosciences PACB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	+1,184,975	New	+$2.12M	﹤0.01%	2296
2024 Q2	–	Sell	-1,789,237	Closed	-$6.71M	–	4483
2024 Q1	$6.71M	Buy	+1,789,237	New	+$10.5M	0.01%	1049
2023 Q4	–	Sell	-330,331	Closed	-$2.76M	–	4634
2023 Q3	$2.76M	Buy	330,331 +270,573	+453%	+$3.09M	0.01%	1210
2023 Q2	$795K	Sell	59,758 -88,183	-60%	-$1.07M	﹤0.01%	1391
2023 Q1	$1.71M	Sell	147,941 -531,332	-78%	-$5.28M	0.01%	1073
2022 Q4	$5.56M	Buy	+679,273	New	+$5.85M	0.03%	634
2022 Q3	–	Sell	-38,385	Closed	-$170K	–	2869
2022 Q2	$170K	Sell	38,385 -71,707	-65%	-$436K	﹤0.01%	1770
2022 Q1	$1M	Buy	+110,092	New	+$1.27M	0.01%	1170
2021 Q2	–	Sell	-67,267	Closed	-$2.24M	–	2658
2021 Q1	$2.24M	Buy	67,267 +28,781	+75%	+$1.01M	0.04%	589
2020 Q4	$998K	Buy	+38,486	New	+$654K	0.01%	878
2020 Q1	–	Sell	-112,100	Closed	-$576K	–	1507
2019 Q4	$576K	Buy	+112,100	New	+$570K	0.02%	884

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PACB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Pacific Biosciences (PACB) in Q1 2026: 1,184,975 shares worth $1.56M. The stake represents ﹤0.01% of the portfolio and ranks #2296 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in PACB as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in PACB in Q4 2019 and has held it in 11 quarters since. The position peaked at $6.71M in Q1 2024. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Qube Research & Technologies (QRT) held 1,184,975 shares of Pacific Biosciences worth $1.56M as of Q1 2026.
Pacific Biosciences was a new Qube Research & Technologies (QRT) position in Q1 2026.
Pacific Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2296 holding.
Qube Research & Technologies (QRT) first reported a position in Pacific Biosciences in Q4 2019 and has held it in 11 quarters since.
Qube Research & Technologies (QRT)'s Pacific Biosciences position peaked at $6.71M in Q1 2024.
229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.